WuXi TIDES, a unique Contract Research and Development Manufacturing Organization (CRDMO) platform, is an integral part of WuXi AppTec. WuXi TIDES offers our worldwide partners efficient, flexible, and high-quality solutions for the drug development of oligonucleotides, peptides and related synthetic conjugates (“TIDES” drugs). We greatly simplify the TIDES drug development by providing all discovery, CMC development and the entire manufacturing supply chain under one roof.

WuXi TIDES has over 1,100 scientists from 10 R&D and manufacturing sites, offering discovery synthesis, process development and manufacturing of novel monomers, linkers and ligands, oligonucleotides, peptides and complex synthetic conjugates at any scale. Beyond chemistry, we offer formulation development, manufacturing, packaging, labeling and distribution in a variety of oral & injectable dosage forms and filling formats. Our comprehensive analytical method development, validation and testing platform supports your TIDES drug development from discovery through clinical to commercial for both drug substance and drug product. Moreover, our regulatory dossier preparation teams are experienced in global fillings of TIDES molecules with all major regulatory agencies.